Aspirin Therapy for Colorectal Cancer With PIK3CA Mutation: Simply Complex!

被引：14
作者：
Fuchs, Charles S. [1 ]
Ogino, Shuji [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 34期
关键词：
NF-KAPPA-B; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RANDOMIZED-TRIAL; BETA-CATENIN; COLON-CANCER; ADENOMAS; PATHWAY; PREVENTION; ACTIVATION; EXPRESSION;
D O I：
10.1200/JCO.2013.52.0080
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：4358 / 4361
页数：4
相关论文
共 49 条
[1]   The AKT/IκB kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-κB and β-catenin [J].
Agarwal, A ;
Das, K ;
Lerner, N ;
Sathe, S ;
Cicek, M ;
Casey, G ;
Sizemore, N .
ONCOGENE, 2005, 24 (06) :1021-1031
[2]   Celecoxib for the prevention of colorectal adenomatous polyps [J].
Arber, Nadir ;
Eagle, Craig J. ;
Spicak, Julius ;
Racz, Istvan ;
Dite, Petr ;
Hajer, Jan ;
Zavoral, Miroslav ;
Lechuga, Maria J. ;
Gerletti, Paola ;
Tang, Jie ;
Rosenstein, Rebecca B. ;
Macdonald, Katie ;
Bhadra, Pritha ;
Fowler, Robert ;
Wittes, Janet ;
Zauber, Ann G. ;
Solomon, Scott D. ;
Levin, Bernard .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (09) :885-895
[3]   A randomized trial of aspirin to prevent colorectal adenomas [J].
Baron, JA ;
Cole, BF ;
Sandler, RS ;
Haile, RW ;
Ahnen, D ;
Bresalier, R ;
McKeown-Eyssen, G ;
Summers, RW ;
Rothstein, R ;
Burke, CA ;
Snover, DC ;
Church, TR ;
Allen, JI ;
Beach, M ;
Beck, GJ ;
Bond, JH ;
Byers, T ;
Greenberg, ER ;
Mandel, JS ;
Marcon, N ;
Mott, LA ;
Pearson, L ;
Saibil, F ;
van Stolk, RU .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (10) :891-899
[4]   A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas [J].
Baron, John A. ;
Sandler, Robert S. ;
Bresalier, Robert S. ;
Quan, Hui ;
Riddell, Robert ;
Lanas, Angel ;
Bolognese, James A. ;
Oxenius, Bettina ;
Horgan, Kevin ;
Loftus, Susan ;
Morton, Dion G. .
GASTROENTEROLOGY, 2006, 131 (06) :1674-1682
[5]   Use of Aspirin postdiagnosis improves survival for colon cancer patients [J].
Bastiaannet, E. ;
Sampieri, K. ;
Dekkers, O. M. ;
de Craen, A. J. M. ;
van Herk-Sukel, M. P. P. ;
Lemmens, V. ;
van den Broek, C. B. M. ;
Coebergh, J. W. ;
Herings, R. M. C. ;
de Velde, C. J. H. van ;
Fodde, R. ;
Liefers, G. J. .
BRITISH JOURNAL OF CANCER, 2012, 106 (09) :1564-1570
[6]   Daily soluble aspirin and prevention of colorectal adenoma recurrence: One-year results of the APACC trial [J].
Benamouzig, R ;
Deyra, J ;
Martin, A ;
Girard, B ;
Jullian, E ;
Piednoir, B ;
Couturier, D ;
Coste, T ;
Little, J ;
Chaussade, S .
GASTROENTEROLOGY, 2003, 125 (02) :328-336
[7]   Celecoxib for the prevention of sporadic colorectal adenomas [J].
Bertagnolli, Monica M. ;
Eagle, Craig J. ;
Zauber, Ann G. ;
Redston, Mark ;
Solomon, Scott D. ;
Kim, KyungMann ;
Tang, Jie ;
Rosenstein, Rebecca B. ;
Wittes, Janet ;
Corle, Donald ;
Hess, Timothy M. ;
Woloj, G. Mabel ;
Boisserie, Frederic ;
Anderson, William F. ;
Viner, Jaye L. ;
Bagheri, Donya ;
Burn, John ;
Chung, Daniel C. ;
Dewar, Thomas ;
Foley, T. Raymond ;
Hoffman, Neville ;
Macrae, Finlay ;
Pruitt, Ronald E. ;
Saltzman, John R. ;
Salzberg, Bruce ;
Sylwestrowicz, Thomas ;
Gordon, Gary B. ;
Hawk, Ernest T. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (09) :873-884
[8]   Effect of aspirin on the Wnt/β-catenin pathway is mediated via protein phosphatase 2A [J].
Bos, C. L. ;
Kodach, L. L. ;
van den Brink, G. R. ;
Diks, S. H. ;
van Santen, M. M. ;
Richel, D. J. ;
Peppelenbosch, M. P. ;
Hardwick, J. C. H. .
ONCOGENE, 2006, 25 (49) :6447-6456
[9]   Aspirin and the risk of colorectal cancer in relation to the expression of COX-2 [J].
Chan, Andrew T. ;
Ogino, Shuji ;
Fuchs, Charles S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (21) :2131-2142
[10]   Aspirin Use and Survival After Diagnosis of Colorectal Cancer [J].
Chan, Andrew T. ;
Ogino, Shuji ;
Fuchs, Charles S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (06) :649-659
12345